<code id='67F81D918D'></code><style id='67F81D918D'></style>
    • <acronym id='67F81D918D'></acronym>
      <center id='67F81D918D'><center id='67F81D918D'><tfoot id='67F81D918D'></tfoot></center><abbr id='67F81D918D'><dir id='67F81D918D'><tfoot id='67F81D918D'></tfoot><noframes id='67F81D918D'>

    • <optgroup id='67F81D918D'><strike id='67F81D918D'><sup id='67F81D918D'></sup></strike><code id='67F81D918D'></code></optgroup>
        1. <b id='67F81D918D'><label id='67F81D918D'><select id='67F81D918D'><dt id='67F81D918D'><span id='67F81D918D'></span></dt></select></label></b><u id='67F81D918D'></u>
          <i id='67F81D918D'><strike id='67F81D918D'><tt id='67F81D918D'><pre id='67F81D918D'></pre></tt></strike></i>

          leisure time

          leisure time

          author:hotspot    Page View:94
          Adam Feuerstein, upper left, moderated a panel with, clockwise, David Chang of Allogene Therapeutics, Rachel Haurwitz of Caribou Biosciences, and Lynelle Hoch of Bristol Myers Squibb. STAT

          If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday.

          Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides. Biotech reporter Adam Feuerstein reminded panelists that Emily Whitehead, the first pediatric patient to receive the therapy at age 10, has just started college.

          advertisement

          But for all its success in changing the lives of up to 7,000 patients to the point one can use the word “cure,” the field has been hampered by wait lists at manufacturers making these patient-specific, autologous therapies and a shortage of medical centers to administer them. Patients bear a burden, too: Training their B cells to attack their tumors requires an onerous depletion process before their cells can be taken out of their bodies.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Today's health inequities arise from racist U.S. history, say experts
          Today's health inequities arise from racist U.S. history, say experts

          JasonFarley,directoroftheCenterforInfectiousDiseaseandNursingInnovationatJohnsHopkinsUniversity,atth

          read more
          Wildfire smoke exposes gaps in outdoor worker protections
          Wildfire smoke exposes gaps in outdoor worker protections

          ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

          read more

          Supreme Court mifepristone arguments center on docs' right to sue

          Abortion-rightsactivistsarearrestedbyU.S.CapitolpoliceastheirprotestoutsideoftheSupremeCourtduringar